Page last updated: 2024-11-02

pentoxifylline and Encapsulating Peritoneal Sclerosis

pentoxifylline has been researched along with Encapsulating Peritoneal Sclerosis in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Excessive fibrin deposition in the peritoneum is thought to be involved in the development of encapsulating peritoneal sclerosis (EPS), an important cause of morbidity and mortality in peritoneal dialysis patients."3.78Fibrin-Induced epithelial-to-mesenchymal transition of peritoneal mesothelial cells as a mechanism of peritoneal fibrosis: effects of pentoxifylline. ( Chiang, CK; Fang, CC; Hu, RH; Huang, JW; Shiao, CH; Shyu, RS; Tsai, TJ; Yen, CJ, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fang, CC1
Huang, JW1
Shyu, RS1
Yen, CJ1
Shiao, CH1
Chiang, CK1
Hu, RH1
Tsai, TJ1

Other Studies

1 other study available for pentoxifylline and Encapsulating Peritoneal Sclerosis

ArticleYear
Fibrin-Induced epithelial-to-mesenchymal transition of peritoneal mesothelial cells as a mechanism of peritoneal fibrosis: effects of pentoxifylline.
    PloS one, 2012, Volume: 7, Issue:9

    Topics: Animals; Blotting, Western; Cells, Cultured; Epithelial Cells; Epithelial-Mesenchymal Transition; Fi

2012